Lu, L.; Zhang, H.; Zhan, M.; Jiang, J.; Yin, H.; Dauphars, D.J.; Li, S.; Li, Y.; He, Y. Antibody Response and Therapy in COVID-19 Patients: Significance in Vaccine Development. Preprints2020, 2020080166. https://doi.org/10.20944/preprints202008.0166.v1
APA Style
Lu, L., Zhang, H., Zhan, M., Jiang, J., Yin, H., Dauphars, D.J., Li, S., Li, Y., & He, Y. (2020). <strong>Antibody Response and Therapy in COVID-19 Patients: Significance in Vaccine Development</strong>. Preprints. https://doi.org/10.20944/preprints202008.0166.v1
Chicago/Turabian Style
Lu, L., Yong Li and You-Wen He. 2020 "<strong>Antibody Response and Therapy in COVID-19 Patients: Significance in Vaccine Development</strong>" Preprints. https://doi.org/10.20944/preprints202008.0166.v1
Abstract
The newly emerged severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has infected millions of people and caused tremendous morbidity and mortality worldwide. Effective treatment for coronavirus disease 2019 (COVID-19) due to SARS-CoV-2 infection is lacking and different therapeutic strategies are under testing. Host humoral and cellular immunity to SARS-CoV-2 infection is a critical determinant for patients’ outcome. SARS-CoV-2 infection results in seroconversion and production of anti-SARS-CoV-2 antibodies. The antibodies may suppress viral replication through neutralization but also might also participate in COVID-19 pathogenesis through a process termed antibody-dependent enhancement. Rapid progress has been made in the research of antibody response and therapy in COVID-19 patients including characterization of the clinical features of antibody responses in different populations infected by SARS-CoV-2, treatment of COVID-19 patients with convalescent plasma and intravenous immunoglobin products, isolation and characterization of a large panel of monoclonal neutralizing antibodies, as well as preliminary clinical results from several COVID-19 vaccine candidates. In this review, we summarize the recent progress and discuss the implications of these findings in vaccine development.
Copyright:
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.